AlphaFold predicted structure
F2R · P25116

Mean pLDDT
74.6/ 100
Confident
425 residues
Confidence breakdown
- Very high(≥ 90)46%
- Confident(70–90)21%
- Low(50–70)7%
- Very low(< 50)25%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
coagulation factor II thrombin receptor
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Bleeding and platelet disorders
BOTH monoallelic and biallelic, autosomal or pseudoautosomalmyocardial infarction
neurodegenerative disease
peripheral arterial disease
stroke disorder
Recurrent thrombophlebitis
preeclampsia
von Willebrand disease 1
dermatitis
neoplasm
coronary artery disorder
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Proteinase-activated receptor 1
High affinity receptor that binds the activated thrombin, leading to calcium release from intracellular stores (PubMed:1672265, PubMed:8136362). The thrombin-activated receptor signaling pathway is mediated through PTX-insensitive G proteins, activation of phospholipase C resulting in the production of 1D-myo-inositol 1,4,5-trisphosphate (InsP3) which binds to InsP3 receptors causing calcium release from the stores (By similarity). In astrocytes, the calcium released into the cytosol allows the Ca(2+)-dependent release of L-glutamate into the synaptic cleft through BEST1, that targets the neuronal postsynaptic GRIN2A/NMDAR receptor resulting in the synaptic plasticity regulation (By similarity). May play a role in platelets activation and in vascular development (PubMed:10079109). Mediates up-regulation of pro-inflammatory cytokines, such as MCP-1/CCL2 and IL6, triggered by coagulation factor Xa (F10) in cardiac fibroblasts and umbilical vein endothelial cells (PubMed:30568593, PubMed:34831181)
F2R · P25116

Mean pLDDT
74.6/ 100
Confident
425 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0